Filippo Andreetta Email Address

Senior Supervisor Discovery Biomarkers

Aptuit, Inc. (formerly Global Pharmaceutical Development, Inc.) is an emerging company focused on streamlining and supporting the drug development process for biotechnology and pharmaceutical innovators. The company was founded by a group of industry experts with extensive market experience who have a track record of building a similar, highly successful company through acquisitions and investment. Download our Corporate Fact Sheet (PDF). Aptuit will provide a comprehensive suite of drug development services and competencies to biotechnology and pharmaceutical innovators worldwide.

Dr Filippo Andreetta is a Senior Supervisor leading the group of Discovery Biomarkers at Aptuit, Verona, Italy. He graduated in Biotechnology at the Verona University in 2003. He joined GlaxoSmithKline in 2003 working in in vitro pharmacology group developing expertise in variety of cellular assay to support the progression of molecule in target validation and lead optimization program. He obtained a PhD in Pharmacology in 2012 from University of Birmingham with a project focused to investigate some biological interactions between neuro-inflammation and some psychiatry diseases. From 2012, his activity was development and validation of cellular immunoassay supporting pharmacology, biomarker analysis, toxicology and PK/PD studies of biologics and small molecule. In the 2017, he was placed as Senior Supervisor of Discovery Biomarkers group to support the development and characterization of translational biomarkers to support studies in late phase of drug discovery and clinical trials. He is a co-author of some publications in international journals.